A physician in 2022 might have spent two hours on the electronic health record for every hour with patients. In 2027, many of those same physicians open a visit, say a quick consent statement, and let software draft the note. That shift did not come from robots or futuristic gadgets. It came from AI software quietly embedded in everyday workflows.
AI software in US healthcare is changing documentation, imaging, billing, scheduling, patient messaging, and population health faster than most administrators predicted. The American Medical Association reported that about two thirds of physicians used some form of health AI in 2024, up sharply from roughly one third the year before. Adoption has continued to climb since then.
Where AI Software Is Already Changing U.S. Healthcare
Clinical Documentation
Documentation is the standout use case. Ambient scribes record patient visits with consent and generate draft notes. Clinicians review and sign them. Health systems report reduced after hours charting and improved clinician satisfaction. Independent analyses suggest the benefits are real but that financial returns vary, and that note accuracy needs ongoing review.
Imaging
AI triages scans, flags urgent findings, and measures lesions. The FDA has authorized well over 1,000 AI enabled devices, and radiology accounts for the majority. Imaging tools often work as second readers or prioritization engines, not replacements.
Revenue Cycle Management
Billing is a major pain point. Administrative costs consume a large share of U.S. healthcare spending, estimated at 15 to 25 percent in various analyses. AI reads clinical notes to suggest codes, predicts claim denials, drafts appeals, and automates eligibility checks. Payers also use AI, which has created an automation arms race around prior authorization.
Scheduling and Operations
Hospitals use predictive models for staffing, bed management, no show prediction, and operating room scheduling. These tools target throughput, a constant challenge in busy hospitals.
Patient Engagement
Chatbots and voice agents answer questions, send reminders, and route messages. Patient portal inboxes expanded after the pandemic, and AI drafted replies help clinicians keep up.
Population Health
Platforms combine data from many sources to identify patients at risk, close care gaps, and manage chronic disease. Health plans and accountable care organizations are heavy users.
Drug Discovery and Precision Medicine
AI helps analyze genomic data, match patients to trials, and design molecules. Companies like Tempus use AI to interpret tumor sequencing and support oncology decisions.
Table 1: Healthcare Workflows Transformed by AI
| Workflow | What AI does | Maturity | Primary beneficiaries |
|---|---|---|---|
| Clinical documentation | Drafts notes from conversations | Early mainstream | Clinicians |
| Imaging | Prioritizes and flags findings | Mature in niches | Radiologists, patients |
| Revenue cycle | Coding, denial prediction, appeals | Growing quickly | Finance teams |
| Scheduling and capacity | Predicts demand and no shows | Growing | Operations leaders |
| Patient messaging | Drafts replies, answers FAQs | Early | Clinicians, patients |
| Population health | Risk stratification, care gap closure | Mature | Payers, ACOs |
| Oncology and genomics | Interprets sequencing data | Established | Oncologists |
| Prior authorization | Automates submissions | Early | Practices, payers |
10 AI Software Platforms Shaping U.S. Healthcare
The following platforms illustrate different workflows. Inclusion is not an endorsement. Evidence and regulatory status are summarized from public information and should be verified.
1. Epic (AI Features and Generative AI Tools)
What it does
Epic Systems is the dominant electronic health record vendor in large U.S. hospitals, and the 2026 KLAS market share report showed it gaining share again while Oracle Health lost ground for a third year. Its AI work sits inside the record clinicians already use. Features include generative drafting of replies to patient portal messages, chart and encounter summaries, AI assistants for clinicians, patients, and billing staff, and predictive models for conditions such as deterioration and no shows. In early 2026 Epic began limited release of a native AI charting tool built on Microsoft’s ambient technology, and it added Ambience Healthcare to its Toolbox program of partner tools. Its Cosmos research database, which pools de identified records from hundreds of millions of patients, supports model development.
How it is redefining care
Because the tools live in the record, adoption does not require a new login, a separate vendor contract, or custom integration. That distribution advantage is reshaping the market, since standalone vendors now compete with features bundled into a system hospitals already pay for. Health systems increasingly choose between a best of breed point solution and a good enough embedded tool.
Approvals and regulation
Epic’s tools are mixed. Documentation and messaging aids generally are not FDA regulated devices, while some predictive models may fall under device rules or federal health IT transparency requirements for decision support. Epic’s sepsis model is the cautionary tale. An external validation published in 2021 found it missed a majority of sepsis cases while generating alerts for a large share of hospitalized patients, and Epic later released a revised version with different design. The episode is cited as proof that local validation is essential.
Key outcomes. Evidence for the embedded generative tools is still emerging, mostly through health system reports of reduced inbox and documentation burden. Independent, controlled outcome data for the newest native tools are limited at the time of writing.
2. Microsoft Dragon Copilot
What it does
Dragon Copilot, launched in March 2025, combines Nuance’s DAX Copilot ambient scribe with Dragon Medical One dictation in a single clinical workflow tool. It listens to a visit with patient consent, drafts the note, summarizes orders, and supports coding and referral letters. Microsoft has extended it to nurses, with documentation tools aimed at bedside workflows. It integrates most deeply with Epic and Oracle Health and also connects to hundreds of other systems. Industry trackers report it is used by more than 600 organizations and supports millions of encounters a month, though these are vendor aligned figures to verify.
How it is redefining care
The product is part of a shift from typing and dictating to conversational documentation, in which the clinician talks to the patient and the record writes itself. Health systems pitch it as a retention tool for clinicians and a way to restore eye contact in the exam room.
Approvals and regulation
It is administrative software, not a cleared medical device, though privacy rules under HIPAA apply and clinicians remain responsible for the final note.
Key outcomes
Results are mixed but generally positive. Cooper University Healthcare reported about 4 minutes saved per patient, or roughly an hour a day, and Intermountain Health reported a 27 percent reduction in time in notes per appointment among regular users. A randomized trial at UCLA Health of 238 physicians across 14 specialties and about 72,000 encounters, published in NEJM AI, compared DAX Copilot and Nabla with usual care and found modest documentation time savings, on the order of 10 percent, and smaller burnout gains. A randomized trial in pediatric subspecialists found better clinician experience and burnout without changing charting time. A large April 2026 JAMA analysis of 8,581 clinicians at five academic centers using Epic, covering Ambience, DAX Copilot, and Abridge, found documentation time fell by about 16 minutes and total EHR time by 13.4 minutes per eight hour shift, with about half a visit more per week, gains the authors called real but modest.
3. Abridge
What it does
Abridge records patient visits and produces structured notes in real time, with a feature called Linked Evidence that ties each statement in the note back to the audio so clinicians can verify it. It integrates deeply with Epic and also connects with Oracle Health and athenahealth. In April 2026 it announced a partnership with NEJM and JAMA Network to let clinicians query published literature during and after visits, and it has extended into prior authorization and coding workflows. It reported a valuation of about $5.3 billion after a $300 million round in 2025.
How it is redefining care
Abridge helped establish the ambient scribe as an enterprise product, winning large academic and integrated systems and earning the Best in KLAS ambient AI designation in 2025 and 2026, according to industry summaries. Its focus on verifiable notes addresses the central trust problem of generative documentation.
Approvals and regulation
It is administrative software and not an FDA cleared device. Performance claims therefore rest on health system studies instead of regulatory review.
Key outcomes
A peer reviewed prospective study at Hawaii Pacific Health Medical Group, published in JMIR Medical Informatics in 2026, found Abridge reduced time providers spent writing notes in clinic and time in the record outside work hours, and the share of physicians reporting no burnout symptoms rose by 22 percent, without a drop in note quality. Mass General Brigham reported a 21.2 percent reduction in burnout prevalence after 84 days of ambient documentation use, and Emory Healthcare saw a 30.7 percent increase in documentation related well being, in studies of ambient tools published in JAMA in 2025. Researchers caution that single site studies cannot yet show effects on cost or long term burnout.
4. Aidoc
What it does
Aidoc’s platform analyzes CT and other imaging studies as they are acquired, flags suspected acute findings, and reprioritizes the radiologist’s worklist. It also coordinates care teams through mobile alerts. Its aiOS enterprise platform manages deployment, data normalization, monitoring, and governance across multiple AI models.
How it is redefining care
In January 2026 the FDA cleared a comprehensive abdominal CT triage solution powered by Aidoc’s CARE foundation model, bringing together 11 newly cleared indications with three previously cleared ones. Aidoc described it as the first clearance of double digit acute indications from a single foundation model. Instead of buying one algorithm per condition, hospitals can deploy a single model that covers conditions such as aortic dissection, appendicitis, bowel obstruction, and spleen injury. The company says this reduces false alerts by roughly an order of magnitude compared with single condition tools, and it plans to extend CARE across CT and X-ray workflows over about 18 months. It raised $150 million in a Series E in April 2026 and reports use in about 2,000 hospitals.
Approvals and regulation
Aidoc holds more than 30 FDA clearances, the most of any pure play clinical AI vendor according to industry trackers, largely as 510(k) cleared triage and notification devices. These are triage aids that do not replace the radiologist’s interpretation.
Key outcomes
In the FDA reviewed pivotal study for the new solution, the 11 new indications showed an average sensitivity of 97 percent and specificity of 98 percent. Earlier research, including work at Yale New Haven Hospital on its stroke tools, reported faster time to treatment for flagged cases. Limitations include alert fatigue if thresholds are poorly tuned and the need for monitoring after deployment.
5. Viz.ai
What it does
Viz.ai detects suspected large vessel occlusion strokes on CT angiography, alerts the stroke team on their phones, and lets specialists review images and coordinate transfer from a community hospital to a comprehensive stroke center. It has expanded into cardiology, aortic disease, pulmonary embolism, and other time critical conditions. Reports describe use in more than 1,700 hospitals and more than 50 FDA clearances, and the company has raised more than $290 million.
How it is redefining care
Viz.ai built the playbook for AI care coordination, in which the algorithm triggers a team workflow, not just a flag on a screen. In 2018 the FDA granted a De Novo authorization to its stroke detection software, the first clearance of an AI triage device, and in 2020 Medicare granted it a new technology add on payment, an early example of CMS reimbursing AI software.
Approvals and regulation
Cleared as 510(k) or De Novo devices for specific intended uses, with performance claims limited to those uses.
Key outcomes
A multicenter study of 474 patients presented at the 2025 International Stroke Conference, as summarized by an industry review, reported a 44 percent reduction in diagnosis time, about 31 minutes faster time to treatment, and 40 percent lower 90 day disability. These results should be checked against the primary publication. Outcomes depend heavily on how well transfer protocols and staffing are built around the alerts.
6. Waystar
What it does
Waystar provides cloud revenue cycle software for hospitals and practices, covering eligibility checks, claims, denial prevention, prior authorization, payments, and patient billing. Its Altitude AI layer applies machine learning and generative tools to predict which claims will be denied, draft appeals, and automate status checks. In 2025 it acquired Iodine Software for $1.25 billion, adding AI for clinical documentation integrity and mid cycle workflows across more than 1,000 hospitals.
How it is redefining care
Administrative cost is a major burden on U.S. healthcare, and denials are one of its main drivers. Waystar’s thesis is that AI works best when it sits where money moves, so it embeds models directly in claims and payment flows. The company says about half its solutions use AI and nearly 40 percent of revenue comes from AI embedded workflows. Payers are using AI too, so the result is an automation contest around approvals and appeals.
Approvals and regulation
It is administrative software and not regulated by the FDA. Compliance concerns center on billing accuracy and the risk of overcoding.
Key outcomes
Waystar crossed $1 billion in annual revenue in 2025. It reports that Altitude AI prevented more than $15 billion in denials for clients in 2025, cut appeal time by 90 percent, and produced double digit increases in denial overturn rates, with 97 percent gross revenue retention. These are company reported results, not independent evaluations.
7. Innovaccer
What it does
Innovaccer sells a healthcare data and AI platform called Gravity, launched in May 2025, that unifies clinical, claims, financial, and operational data from more than 80 electronic health record systems into one layer. On top sits Agents of Care, introduced in February 2025, a suite of pre trained AI agents for patient intake, prior authorization, care management, coding, denial management, and call centers. It acquired the virtual cardiology company Story Health in 2025 and added revenue cycle assets in 2026.
How it is redefining care
The company argues that AI is only as useful as the data beneath it, so it sells the data foundation and the agents together. Its customers include large systems such as Kaiser Permanente, Ascension, Trinity Health, and Banner Health, which link contact center agents to population health programs. It committed $250 million over three years in April 2026 to expand the agent platform and sells through AWS Marketplace.
Approvals and regulation
Mostly administrative and analytic software, not FDA regulated, though some clinical decision support features may be subject to oversight.
Key outcomes
Innovaccer raised a $275 million Series F in January 2025 at a valuation near $3.45 billion, bringing total funding to $675 million, and a July 2026 report said annual recurring revenue crossed $200 million. It was named a leader in Gartner’s first Magic Quadrant for healthcare provider industry cloud platforms. Customer savings and outcome figures come from the company’s case studies and should be treated accordingly.
8. Qventus
What it does
Qventus applies AI to hospital operations. Its platform automates tasks in surgical scheduling, patient flow, discharge planning, and care coordination, and in 2025 it launched a perioperative care coordination solution aimed at reducing unnecessary surgery cancellations and an AI Operational Assistant that takes on administrative work for care teams.
How it is redefining care
Capacity is a bottleneck in many hospitals, with operating rooms idle on some days and overbooked on others. By predicting delays, filling open slots, and nudging patients and staff before problems arise, the software aims to raise throughput without building new space. The company raised $105 million led by KKR in 2025, a sign of investor appetite for operations focused AI.
Approvals and regulation
It is operations software and not an FDA regulated device.
Key outcomes
Results are typically reported as operational metrics, such as fewer cancellations, shorter stays, and more completed cases, and come from customer reports rather than independent studies. Quality depends on clean data from the record and staff willingness to act on recommendations.
9. Tempus
What it does
Tempus combines molecular testing, clinical data, and AI to guide cancer care and drug development. It offers tumor sequencing, hereditary testing through its Ambry Genetics acquisition, a database of linked clinical and genomic records, and more than 50 algorithms that analyze genomic, imaging, and pathology data. It acquired Paige, a digital pathology AI company, in August 2025, and it is rolling out a generative AI clinical copilot called David with Northwestern Medicine.
How it is redefining care
Tempus aims to make data driven precision oncology a routine part of care, matching patients with targeted therapies and clinical trials and licensing de identified data to pharmaceutical partners. Revenue guidance for 2025 was about $1.265 billion, roughly 80 percent growth, driven by genomic testing volume and the Ambry deal.
Approvals and regulation
Tempus holds several FDA authorizations, including an approved companion diagnostic for its xT CDx tumor profiling test, a 510(k) clearance for its Tempus Pixel cardiac imaging platform, and clearance for ECG software that identifies patients who may have low ejection fraction. Paige Prostate, now part of Tempus, received an FDA De Novo authorization in 2021 as the first AI tool to assist in detecting cancer on pathology slides.
Key outcomes
The company reports that physicians who order more than five oncology tests retain at an 87 percent rate over 12 months, a commercial measure of adoption. Clinical outcome data on whether broader testing improves survival are still developing, and reimbursement and cost remain limits.
10. Notable Health
What it does
Notable builds AI agents that automate front office and revenue cycle tasks: patient intake and registration, scheduling, referrals, insurance verification, charting prep, and outreach. Its approach combines robotic process automation, which works across existing systems of record, with language models that can converse with patients and staff.
How it is redefining care
Rather than replacing systems, Notable acts as a layer that fills in forms, checks eligibility, and updates the record, tasks that consume large amounts of staff time. Industry reports cite deployments at more than 45 health systems, including Sutter Health and Tampa General, and a partnership with CommonSpirit Health on intake and charting. In January 2026 another health system announced it would use Notable for registration automation and value based care support.
Approvals and regulation
It is administrative software without FDA regulation, though privacy, security, and consent rules apply to patient facing conversations.
Key outcomes
Health systems cite fewer calls, faster intake, and improved access, but published independent outcome studies are limited. Reliable handoffs to humans when patients need help are the main safety design question, and the category is crowded with competitors and with bundled agents from large electronic record vendors.
Table 2: 10 Software Platforms
| Platform | Company | Workflow | AI capability | Regulatory note | Known limitation |
|---|---|---|---|---|---|
| Epic AI tools | Epic Systems | EHR and messaging | Summaries, drafts, predictive models | Varies by feature | Model validation locally |
| Dragon Copilot | Microsoft | Documentation | Ambient notes, dictation | Administrative | Clinician review |
| Abridge | Abridge | Documentation | Ambient notes with evidence links | Administrative | Competition, accuracy |
| Aidoc | Aidoc | Imaging triage | Detection of urgent findings | FDA cleared modules | False alerts |
| Viz.ai | Viz.ai | Stroke and cardiology | Detection and care coordination | FDA cleared modules | Workflow dependent |
| Waystar | Waystar | Revenue cycle | Denial prevention, claims | Administrative | Payer provider arms race |
| Innovaccer | Innovaccer | Population health | Data unification, risk scoring | Mostly administrative | Data interoperability |
| Qventus | Qventus | Hospital operations | Scheduling and flow prediction | Administrative | Data quality |
| Tempus | Tempus | Oncology and genomics | Sequencing analysis, insights | Some FDA cleared products | Cost, reimbursement |
| Notable | Notable Health | Patient intake and scheduling | AI agents | Administrative | Escalation reliability |
Why Adoption Is Accelerating
Workforce Pressure
The U.S. faces shortages of nurses, physicians, and technicians. The Association of American Medical Colleges has projected a physician shortage of up to 86,000 by 2036. Software that frees clinician time is attractive when hiring cannot keep up.
Administrative Burden
Physicians report spending large amounts of time on documentation and inbox messages. Prior authorization alone consumes dozens of staff hours per practice each week, according to AMA surveys. Automating those tasks offers fast, visible returns.
Data Availability
Electronic health records now cover nearly all hospitals. Digital data allow models to be trained and deployed. Federal rules on data sharing, including the information blocking provisions of the 21st Century Cures Act, push further interoperability.
EHR Integration
Embedding AI inside the record removes friction. When a tool appears in the workflow clinicians already use, adoption is easier. That advantage strengthens the position of large vendors.
Investment
Venture funding for health AI has surged, with generative AI startups raising large rounds. Health systems also fund pilots through innovation budgets. Competition spurs rapid product development.
Generative AI
Large language models made unstructured text, the bulk of clinical information, usable at scale. Tasks once considered too variable, such as summarizing a chart, are now feasible.
Table 3: Adoption Opportunities Versus Implementation Risks
| Opportunity | Related risk | Mitigation |
|---|---|---|
| Less documentation time | Inaccurate notes entering the record | Clinician review, audit programs |
| Faster imaging triage | Alert fatigue, false positives | Threshold tuning, feedback loops |
| Higher revenue capture | Overcoding and compliance exposure | Compliance monitoring |
| Better access through automation | Patients unable to reach a human | Clear escalation paths |
| Population risk targeting | Algorithmic bias | Fairness testing across groups |
| Efficiency gains | Staff displacement fears | Reskilling, transparent communication |
| Faster research | Privacy of training data | De identification, governance |
Where AI Still Struggles
Hallucinations
Generative models can produce plausible but false statements. In clinical notes, a fabricated detail can mislead later care. That is why human review remains a safeguard.
Bias
Models trained on skewed data may perform worse for some groups. A widely cited 2019 study found that a commercial risk algorithm underestimated the needs of Black patients because it used past spending as a proxy for illness. Monitoring performance across populations is essential.
Privacy
Health data are sensitive. Using AI vendors requires business associate agreements under HIPAA and attention to how data are stored and used for model training.
Interoperability
Even with digital records, data are fragmented across systems and formats. AI tools can only work with the data they receive.
Validation
Many tools are evaluated in retrospective studies. Fewer have randomized trials showing better patient outcomes. Real world performance can degrade when populations or workflows change.
Liability
Responsibility for errors remains unsettled. Clinicians generally remain accountable for decisions, which can discourage heavy reliance on tools they cannot fully inspect.
The World Health Organization emphasizes that healthcare AI needs attention to safety, equity, accountability, transparency, and human rights.
General Purpose AI Versus Regulated Clinical Software
A clear line separates general chat assistants from regulated clinical software. Chatbots built for broad use are not cleared as medical devices. Clinical software that diagnoses or guides treatment can fall under FDA oversight, and the agency applies risk based pathways to AI enabled devices.
The Office of the National Coordinator for Health IT adopted rules requiring greater transparency for certain predictive decision support tools in certified records. That policy pushes vendors to disclose training data and performance. Hospitals should ask vendors which category a tool falls into and request evidence appropriate to that category.
What Comes Next
AI software will likely become infrastructure, as unremarkable as email within healthcare. The next phase will focus on proving outcomes, reducing errors, and extending beyond administrative tasks into care delivery. Organizations that pair automation with strong governance will gain the most.
Workers will see their roles change, but evidence so far suggests AI is easing workload more than replacing staff. Patients may notice shorter waits, more responsive portals, and clinicians who look at them rather than a screen. The challenge for 2027 and beyond is making sure these benefits reach safety net hospitals and rural clinics as well as flagship systems.
What Implementation Looks Like Inside a Hospital
Buying software is the easy step. Most of the value, and most of the failure, happens during implementation. Health systems that succeed with AI tend to follow a similar sequence.
Start with a defined problem. Successful programs begin with a measurable pain point, such as clinicians finishing notes at home, radiology turnaround for stroke studies, or claim denials in one specialty. Projects that begin with a technology and search for a use case often stall.
Form a governance group. A multidisciplinary committee that includes clinicians, nurses, informatics staff, compliance, privacy, legal, and patient representatives reviews each proposal. The group decides which tools need formal validation, which need monitoring, and which are low risk administrative aids.
Run a bounded pilot. A pilot with a small group of volunteer users, clear baseline metrics, and a fixed duration shows whether a tool works in local conditions. For ambient documentation, typical metrics include time spent in the record outside clinic hours, note completion time, visit capacity, clinician satisfaction, and patient experience. Safety reviews of sample notes catch errors early.
Train and support users. Clinicians need to learn how to prompt, review, and correct outputs. A tool that saves time for enthusiastic users can add work for others if training is poor. Peer champions and quick support channels improve adoption.
Monitor continuously. After launch, teams track accuracy audits, override rates, alert acceptance, equity across patient groups, and complaints. Predefined thresholds trigger retraining, workflow changes, or shutdown.
Plan for change. Vendors update models, and electronic health record upgrades can alter data inputs. Contracts should require notice of material changes and access to performance data.
Smaller hospitals and rural clinics face an extra challenge, since they have fewer informatics staff to run governance and monitoring. Shared services, regional collaboratives, and vendor support can help, but the principle holds: AI is a clinical and operational program, not a software installation. Organizations that treat it that way tend to capture the gains and limit the harms.
FAQ
Q: What AI software is used in U.S. healthcare?
A: Common examples include ambient documentation tools, imaging triage systems, revenue cycle software, scheduling platforms, and AI features inside electronic health records. Specific products include Epic AI tools, Dragon Copilot, Abridge, Aidoc, and Viz.ai.
Q: How is AI reducing administrative work?
A: AI drafts clinical notes, suggests billing codes, predicts claim denials, and automates scheduling and intake. These tasks consume large amounts of staff time.
Q: Is healthcare AI regulated?
A: It depends on the function. Software that diagnoses or guides treatment may be an FDA regulated medical device. Administrative tools generally are not. Federal health IT rules also require transparency for some decision support tools.
Q: What are the biggest risks?
A: Risks include inaccurate outputs, bias, privacy problems, overreliance, and unclear liability. Human oversight and local validation reduce them.
Q: Will AI replace healthcare workers?
A: Current evidence points to AI changing tasks rather than eliminating most jobs. Workforce shortages make time saving tools attractive.
Q: How many doctors use AI?
A: An AMA survey found about two thirds of physicians used health AI in 2024, up from roughly one third in 2023. Usage has likely grown since.
Q: Do AI scribes work?
A: Studies and health system reports show less documentation time and better clinician satisfaction. Accuracy and financial benefits vary, so review remains necessary.
Q: What is the difference between general AI and clinical AI?
A: General AI chatbots are built for broad use and are not cleared for diagnosis. Clinical AI is designed and validated for specific medical purposes and may be regulated.
Q: How should hospitals evaluate AI vendors?
A: Ask about evidence, regulatory status, local validation, integration, data use, and monitoring. Involve clinicians, compliance staff, and patients.